320 related articles for article (PubMed ID: 1826793)
1. Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion.
Eugui EM; Almquist SJ; Muller CD; Allison AC
Scand J Immunol; 1991 Feb; 33(2):161-73. PubMed ID: 1826793
[TBL] [Abstract][Full Text] [Related]
2. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
Allison AC; Eugui EM
Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice.
Eugui EM; Mirkovich A; Allison AC
Scand J Immunol; 1991 Feb; 33(2):175-83. PubMed ID: 2017655
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.
Quéméneur L; Flacher M; Gerland LM; Ffrench M; Revillard JP; Bonnefoy-Berard N
J Immunol; 2002 Sep; 169(5):2747-55. PubMed ID: 12193749
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection.
Allison AC; Eugui EM
Transplantation; 2005 Oct; 80(2 Suppl):S181-90. PubMed ID: 16251851
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines.
Cohn RG; Mirkovich A; Dunlap B; Burton P; Chiu SH; Eugui E; Caulfield JP
Transplantation; 1999 Aug; 68(3):411-8. PubMed ID: 10459546
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil and its mechanisms of action.
Allison AC; Eugui EM
Immunopharmacology; 2000 May; 47(2-3):85-118. PubMed ID: 10878285
[TBL] [Abstract][Full Text] [Related]
8. Inosine monophosphate dehydrogenase (IMPDH) inhibition in vitro suppresses lymphocyte proliferation and the production of immunoglobulins, autoantibodies and cytokines in splenocytes from MRLlpr/lpr mice.
Jonsson CA; Carlsten H
Clin Exp Immunol; 2001 Jun; 124(3):486-91. PubMed ID: 11472413
[TBL] [Abstract][Full Text] [Related]
9. In vitro effects of mycophenolic acid on cell cycle and activation of human lymphocytes.
Heinschink A; Raab M; Daxecker H; Griesmacher A; Müller MM
Clin Chim Acta; 2000 Oct; 300(1-2):23-8. PubMed ID: 10958860
[TBL] [Abstract][Full Text] [Related]
10. Effects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T cell activation molecule expression in human mixed lymphocyte cultures.
Thomson AW; Woo J; Yao GZ; Todo S; Starzl TE; Zeevi A
Transpl Immunol; 1993; 1(2):146-50. PubMed ID: 7521738
[TBL] [Abstract][Full Text] [Related]
11. [The effect of mycophenolic acid on activation antigen expression and in vitro T lymphocytes proliferation in peripheral blood].
Zheng W; Huang H; Xu C
Zhonghua Nei Ke Za Zhi; 2002 May; 41(5):329-32. PubMed ID: 12133428
[TBL] [Abstract][Full Text] [Related]
12. Role of monocytes in the up-regulation of the early activation marker CD69 on B and T murine lymphocytes induced by microbial mitogens.
Vilanova M; Tavares D; Ferreira P; Oliveira L; Nóbrega A; Appelberg R; Arala-Chaves M
Scand J Immunol; 1996 Feb; 43(2):155-63. PubMed ID: 8633195
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism.
Dayton JS; Turka LA; Thompson CB; Mitchell BS
Mol Pharmacol; 1992 Apr; 41(4):671-6. PubMed ID: 1569921
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolic acid and methotrexate inhibit lymphocyte cytokine production via different mechanisms.
de Lathouder S; Gerards AH; de Groot ER; Valkhof M; Aarden LA
Eur Cytokine Netw; 2002; 13(3):317-23. PubMed ID: 12231475
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of action of mycophenolate mofetil.
Allison AC
Lupus; 2005; 14 Suppl 1():s2-8. PubMed ID: 15803924
[TBL] [Abstract][Full Text] [Related]
16. In vitro effects of mycophenolic acid on the nucleotide pool and on the expression of adhesion molecules of human umbilical vein endothelial cells.
Raab M; Daxecker H; Karimi A; Markovic S; Cichna M; Markl P; Müller MM
Clin Chim Acta; 2001 Aug; 310(1):89-98. PubMed ID: 11485760
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolic acid inhibits maturation and function of human dendritic cells and B cells.
Wadia PP; Herrera ND; Abecassis MM; Tambur AR
Hum Immunol; 2009 Sep; 70(9):692-700. PubMed ID: 19445989
[TBL] [Abstract][Full Text] [Related]
18. In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443.
Allison AC; Almquist SJ; Muller CD; Eugui EM
Transplant Proc; 1991 Apr; 23(2 Suppl 2):10-4. PubMed ID: 2063415
[No Abstract] [Full Text] [Related]
19. Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics.
Gummert JF; Barten MJ; Sherwood SW; van Gelder T; Morris RE
J Pharmacol Exp Ther; 1999 Dec; 291(3):1100-12. PubMed ID: 10565830
[TBL] [Abstract][Full Text] [Related]
20. Brequinar sodium, mycophenolic acid, and cyclosporin A inhibit different stages of IL-4- or IL-13-induced human IgG4 and IgE production in vitro.
Chang CC; Aversa G; Punnonen J; Yssel H; de Vries JE
Ann N Y Acad Sci; 1993 Nov; 696():108-22. PubMed ID: 7509129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
